Medline
$35.61Change from previous close: +1.92%Absolute change: +$0.67
At a glance
- Net margin
- 4.1%
- 2025
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 28,432 | — | — | — |
| Cost of revenue | 20,914 | — | — | — |
| Gross profit | 7,518 | — | — | — |
| Selling, general and administrative | 4,524 | — | — | — |
| Operating income | 2,212 | — | — | — |
| EBIT | 2,060 | — | — | — |
| EBITDA | 3,071 | — | — | — |
| Interest expense | 812 | — | — | — |
| Pre-tax income | 1,248 | — | — | — |
| Income tax | 91.0 | — | — | — |
| Net income | 1,159 | — | — | — |
| Net income to common shareholders | 1,159 | — | — | — |
| Basic EPS | -0.01 | 0.66 | 0.13 | -0.01 |
| Diluted EPS | -0.01 | 0.66 | 0.13 | -0.01 |
| Average shares (basic) | 810 | 1,828 | 1,828 | 1,828 |
| Average shares (diluted) | 810 | 1,828 | 1,828 | 1,828 |